entity

ERG

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ERG: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections

30Hypotheses

0Analyses

0Outgoing

1Incoming

12Experiments

0Debates

No AI portrait yet

Wiki Pages (2)

Knowledge base pages for this entity

hERG Protein

protein · 659 words

→

KCNH6 Protein (ERG2 Potassium Channel)

protein · 651 words

→

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (1)

Source	Relation	Type	Str
SPOP	degrades	protein	0.85

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa	0.887	-	Do β-amyloid plaques and neurofibrillary
Gamma Oscillation Enhancement Synergy	0.838	neurodegeneration	Does the cancer-cystatin-C-TREM2 pathway
NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic A	0.790	neurodegeneration	epigenetic reprogramming aging neurons
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate	0.785	-	Do β-amyloid plaques and neurofibrillary
LAMP2A Liquid-Liquid Phase Separation Defects in Dopaminergi	0.783	neurodegeneration	-

PINK1/Parkin–TREM2 Axis: Convergent Mitophagy Failure Unifie	0.780	neurodegeneration	-
Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Choli	0.769	-	Do β-amyloid plaques and neurofibrillary
SASP-Mediated Cholinergic Synapse Disruption	0.763	neurodegeneration	Senolytic therapy for age-related neurod
TREM2 Crosstalk and Synergistic Activation of Phagocytic Tra	0.761	neuroinflammation	What molecular mechanisms mediate SPP1-i
Cholinergic Basal Forebrain-Hippocampal Circuit Protection	0.760	neuroscience	Circuit-level neural dynamics in neurode
Synaptic Vesicle Cycle Hijacking: Shared Convergent Mechanis	0.760	neurodegeneration	-
PARP1-NAD+-AIF bioenergetic collapse drives a self-amplifyin	0.760	neurodegeneration	What mechanisms drive the self-amplifyin
Dopaminergic Ventral Tegmental-Hippocampal Circuit Protectio	0.751	neuroscience	Circuit-level neural dynamics in neurode
GBA1 Loss Triggers a TFEB-to-TFE3 Compensatory Switch in A9	0.750	neurodegeneration	-
Endosomal trafficking defects are the common upstream lesion	0.730	neurodegeneration	What determines the temporal sequence of
Purinergic Signaling Polarization Control	0.713	neurodegeneration	Astrocyte reactivity subtypes in neurode
Noradrenergic-Tau Propagation Blockade	0.711	neurodegeneration	Sleep disruption as cause and consequenc
Creatine Kinase System Capacity as Neural Energy Reserve Bio	0.707	translational-neuroscience	Which metabolic biomarkers can distingui
Purinergic P2Y12 Inverse Agonist Therapy	0.703	neurodegeneration	Synaptic pruning by microglia in early A
Microglial Purinergic Reprogramming	0.701	neurodegeneration	4R-tau strain-specific spreading pattern
Lysosomal Acidification Failure: Convergent GBA1/LAMP2A–medi	0.700	neurodegeneration	-
NRF2-Mediated Proteostatic Convergence: Shared Oxidative Str	0.700	neurodegeneration	-
VPS35 Retromer Dysfunction Creates a GCase Trafficking Bottl	0.700	neurodegeneration	-
Multi-Target Synergy via Presynaptic Vesicle Hub Convergence	0.683	neurodegeneration	What molecular mechanisms underlie Atrem
mTORC1 Reactivation as Autophagy-Senescence Divergence Point	0.682	molecular-biology	What is the optimal therapeutic window t
TREM2 R47H variant synergizes with APOE4 to collapse microgl	0.681	neuroscience	APOE4-driven lipid metabolism dysregulat
Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A	0.669	neurodegeneration	What are the mechanisms by which gut mic
Glymphatic-Cholinergic Tau Clearance Cascade	0.666	neuroscience	Circuit-level neural dynamics in neurode
Complement C1QA Inhibition Synergizes with PV Interneuron Mo	0.659	neurodegeneration	What molecular mechanisms underlie the d
eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote	0.000	als	-

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (12)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
Plasma ATN biomarkers across AD continuum in Chilean cohort	clinical	Alzheimer's disease	0.950	0.00	Chilean older adults (n=318) w	proposed	N/A
Epigenetic clocks association with brain aging patterns in older women	exploratory	cognitive impairment and demen	0.900	0.00	human patients	proposed	N/A
Tau depletion effects on neuronal development in primary cultures	exploratory		0.900	0.00	primary rodent neuronal cultur	proposed	N/A
Differential GWAS of schizophrenia vs PTSD	exploratory	schizophrenia, post-traumatic	0.900	0.00	human patients - European ance	proposed	N/A
Tau depletion effects on neuronal development in primary cultures	exploratory		0.900	0.00	primary rodent neuronal cultur	proposed	N/A
Creation and validation of 3xAD-ChAT-Cre mouse model	validation	Alzheimer's disease	0.900	0.00	3xAD-ChAT-Cre transgenic mice	proposed	N/A
GTEx brain tissue expression analysis of MAPT/CRHR1 locus	exploratory	schizophrenia, post-traumatic	0.850	0.00	human brain tissue samples fro	proposed	N/A
Microtubule domain analysis in adult axons	exploratory		0.800	0.00	adult rodent axons	proposed	N/A
Tau depletion effects on microtubule domains in adult axons	exploratory		0.800	0.00	adult rodent neurons	proposed	N/A
40 Hz Auditory + Visual Gamma Stimulation Reduces Amyloid and Entrains	in_vivo	Alzheimer's disease	0.772	0.68	5xFAD mice 4-6 months, LFP imp	proposed	$72,000
Cholinergic System Dysfunction in DLB — Mechanisms and Therapeutic Res	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000
Mixed Pathology Effects on Parkinson's Disease Progression and Treatme	clinical	Alzheimer's Disease	0.400	0.50	human	proposed	$5,460,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Clinical, Immunological, and Vesicular Markers in Sarcopenia and Presarcopenia. [PMID:40917056]	Shuliko LM, Svarovsky DA, Spirina LV, Og	Front Biosci (Landmark Ed)	2025	1
CD47-blocking antibody interferes with neutrophil extracellular traps formation [PMID:39951937]	Diao Y, Hao M, Xie M, Hu X, Tan R, Wang	J Neuroimmunol	2025	1
Asparagine Endopeptidase Inhibition Attenuates Tissue Plasminogen Activator-Indu [PMID:40116141]	Xie G, Jiang G, Huang L, Sun S, Li X, Wu	CNS Neurosci Ther	2025	1
Enhanced anticancer activity of nanoemulsified cardamom extract via modulation o [PMID:41658858]	["Soltani T", "Karimian M", "Vaziri H",	Biochemistry and biophysics re	2026	0
Integrated transcriptomic, proteomic, and metabolomic analyses reveal molecular [PMID:41850064]	["Wang H", "Liu Y", "Jiang K", "Yin J",	Poultry science	2026	0
Fragment merging design, synthesis, and biological evaluation of novel methyl Se [PMID:41785527]	["Shaaban S", "Hawas S", "Elmaaty A", "B	Bioorganic & medicinal chemist	2026	0
Theranekron modulates extracellular matrix and apoptotic signaling pathways in c [PMID:41852375]	["Kuccukturk S", "Duran T", "Vanli S", "	Cytotechnology	2026	0
Saliva liquid biopsy: MMP2, MMP9, and TIMP2 as potential diagnostic biomarkers i [PMID:41779471]	["Cruz-Romero S", "Baldi\u00f3n A", "Taw	Journal of applied oral scienc	2026	0
Glomerular Transcriptome Analysis Reveals Endothelial Disturbances in Patients W [PMID:41659822]	["Nelson-Taylor S", "Troost J", "Giannin	Kidney medicine	2026	0
Encapsulation of hydroxyurea in exosomes derived from adipose mesenchymal stem c [PMID:41702234]	["Taheri Kangarshahi Z", "Ganji S", "Ash	Translational oncology	2026	0
NSUN2 promoted tumor growth and metastatic via m [PMID:41794778]	["Li R", "Jin D", "Shao S", "Guo J"]	Cell death & disease	2026	0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025	0
Membrane-Type 5 Matrix Metalloproteinase (MT5-MMP): Background and Proposed Role [PMID:40867559]	["Jadhav D", "Knapinska A", "Wang H", "F	Biomolecules	2025	0
Pyridostigmine Treatment Significantly Alleviates Isoprenaline-Induced Chronic H [PMID:40725139]	Marinković ST, Sobot T, Maksimović ŽM, Ð	International journal of molec	2025	0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025	0
Increased Neuronal Expression of the Early Endosomal Adaptor APPL1 Replicates Al [PMID:40514243]	Jiang Y, Sachdeva K, Goulbourne CN, Berg	The Journal of neuroscience :	2025	0
Effects of Mono- (2-ethylhexyl) phthalate and Phthalic Acid Monobenzyl Ester on [PMID:40769497]	["Wu Q", "Sun Y", "Liu Q", "Zhao X", "Li	Reproductive toxicology (Elmsf	2025	0
Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer [PMID:39858430]	["Shoari A", "Ashja Ardalan A", "Dimesa	Biomolecules	2024	0
Effects of MMP2 and its inhibitor TIMP2 on DNA damage, apoptosis and senescence [PMID:39538054]	["Deng X", "Zhang Y", "He X", "Li L", "Y	Journal of bioenergetics and b	2024	0
Biological significance and pathophysiological role of Matrix Metalloproteinases [PMID:39322129]	["Ganguly K", "Adhikary K", "Acharjee A"	International journal of biolo	2024	0

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning ERG in their description or question text

Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Cholinergic Signaling

Score: 0.769 · unknown disease · 2026-04-12

## Mechanistic Overview Direct Toxicity Hypothesis: β-Amyloid Directly Impairs Cholinergic Signaling starts from the cla

SASP-Mediated Cholinergic Synapse Disruption

Score: 0.763 · neurodegeneration · 2026-04-02

## Mechanistic Overview SASP-Mediated Cholinergic Synapse Disruption starts from the claim that modulating MMP2/MMP9 wit

TREM2 Crosstalk and Synergistic Activation of Phagocytic Transcriptome

Score: 0.761 · neuroinflammation · 2026-04-22

**Molecular Mechanism and Rationale** The molecular mechanism underlying SPP1-TREM2 crosstalk centers on the synergisti

Cholinergic Basal Forebrain-Hippocampal Circuit Protection

Score: 0.760 · neuroscience · 2026-04-07

## **Molecular Mechanism and Rationale** The cholinergic basal forebrain-hippocampal circuit protection hypothesis cent

PARP1-NAD+-AIF bioenergetic collapse drives a self-amplifying parthanatos loop

Score: 0.760 · neurodegeneration · 2026-04-25

Oxidative DNA damage hyperactivates PARP1, rapidly consuming NAD+ and collapsing ATP production. Bioenergetic failure im

Dopaminergic Ventral Tegmental-Hippocampal Circuit Protection

Score: 0.751 · neuroscience · 2026-04-07

## Mechanistic Overview Dopaminergic Ventral Tegmental-Hippocampal Circuit Protection starts from the claim that modulat

Endosomal trafficking defects are the common upstream lesion linking APP process

Score: 0.730 · neurodegeneration · 2026-04-25

AD-risk trafficking defects in SORL1/BIN1/PICALM/retromer may generate parallel early outputs: amyloidogenic APP sorting

Purinergic Signaling Polarization Control

Score: 0.713 · neurodegeneration · 2026-04-02

## Mechanistic Overview Purinergic Signaling Polarization Control starts from the claim that modulating P2RY1 and P2RX7

Noradrenergic-Tau Propagation Blockade

Score: 0.711 · neurodegeneration · 2026-04-02

## Mechanistic Overview Noradrenergic-Tau Propagation Blockade starts from the claim that modulating ADRA2A within the d

Creatine Kinase System Capacity as Neural Energy Reserve Biomarker

Score: 0.707 · translational-neuroscience · 2026-04-16

## Mechanistic Overview Creatine Kinase System Capacity as Neural Energy Reserve Biomarker starts from the claim that mo

Purinergic P2Y12 Inverse Agonist Therapy

Score: 0.703 · neurodegeneration · 2026-04-02

## Mechanistic Overview Purinergic P2Y12 Inverse Agonist Therapy starts from the claim that modulating P2RY12 within the

Microglial Purinergic Reprogramming

Score: 0.701 · neurodegeneration · 2026-04-02

## Mechanistic Overview Microglial Purinergic Reprogramming starts from the claim that modulating P2RY12 within the dise